Recent Quotes (30 days)

You have no recent quotes
chg | %

Johnson Matthey PLC  

(Public, LON:JMAT)   Watch this stock  
Find more results forJMAT
2,609.33
-27.67 (-1.05%)
May 24 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 2,593.00 - 2,645.00
52 week 2,014.00 - 2,699.00
Open 2,638.00
Vol / Avg. 524,744.00/187.00
Mkt cap 5,346.94M*
P/E 17.39
Div/yield 15.50/2.20*
EPS 1.50*
Shares 204.92M
Beta     -
Inst. own     -
*GBP
Jul 25, 2013
Johnson Matthey PLC Annual Shareholder Meeting Add to calendar
Jun 6, 2013
Full Year 2012/2013 Johnson Matthey PLC Earnings Release Add to calendar
  

Key stats and ratios

Q3 (Sep '12) 2012
Net profit margin 2.98% 2.62%
Operating margin 3.99% 3.60%
EBITD margin - 4.79%
Return on average assets 9.01% 9.68%
Return on average equity 20.29% 21.53%
Employees 10,058 -
Carbon Disclosure Rating - 73/100

Address

5th Floor 25 Farringdon Street
LONDON, ENG EC4A 4AB
United Kingdom - Map
+44-20-72698400 (Phone)
+44-20-72698433 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance
Discussion Group - Google Finance

Description

Johnson Matthey Plc is a global specialty chemicals company operating in three divisions: Environmental Technologies, Precious Metal Products and Fine Chemicals. Environmental Technologies is a supplier of catalysts and related technologies for applications, such as pollution control, cleaner fuel, hydrocarbons and the hydrogen economy. Precious Metal Products� activities comprise the marketing, distribution, refining and recycling of platinum group metals (pgms), fabrication of products using precious metals and related materials, manufactures pgm and base metal catalysts and pgm chemicals. Fine Chemicals is a supplier of active pharmaceutical ingredients, fine chemicals and other specialty chemical products and services to chemical and pharmaceutical industry�s customer supplier of catalysts. In March 2012, Endo Pharmaceuticals Holdings Inc. acquired U.S. patent 7,851,482 B2 for oxymorphone hydrochloride from the Company. In March 2013, the Company acquired Formox AB.

Officers and directors

Niel A. P. Carson Chief Executive, Executive Director
Age: 55
Robert J. MacLeod Group Finance Director, Executive Director
Larry C. Pentz Executive Director - Environmental Technologies, Director
Age: 57
W. F. Sandford Executive Director - Precious Metal Products, Director
Age: 59
Simon Farrant Group Legal Director, Company Secretary
Timothy E.P. Stevenson OBE Non-Executive Chairman of the Board
Age: 64
Colin S. Matthews Non-Executive Director
Age: 56
Alan M. Ferguson Independent Non-Executive Director
Age: 55
Michael J. Roney Senior Independent Non-Executive Director
Age: 58
Dorothy C. Thompson Independent Non-Executive Director